<DOC>
	<DOCNO>NCT00839358</DOCNO>
	<brief_summary>The aim study evaluate effect prolong administration albumin midodrine prevention complication ( renal failure , sepsis , hemorrhage , hepatic encephalopathy hyponatremia ) patient cirrhosis wait list liver transplantation . One hundred ninety four patient cirrhosis await liver transplantation include study . Patients randomize receive albumin midodrine ( treatment group ) administration placebo ( saline albumine ) tablets excipients without midodrine ( control group ) . Patients followed-up 12th month . In treatment group albumin give dose 40g every 15 day midodrine 5mg tid , addition lactitol ( conventional dos ) specific treatment patient require cirrhosis . The group control receive placebo way treatment group addition lactitol specific treatment require disease . In patient liver renal function test , hormone determination ( renin , aldosterone , noradrenaline ) , cytokine determine basal condition . All determination repeat month 1st,3rd , 6th 12th month . Before inclusion study neuropsychological test critical flicker test perform diagnose minimum EH . These test repeat 3rd , 6th 12th month . All determination repeat time patient develop complication consider end point . In baseline condition 3rd 6th month questionnaire quality life ( SF36 ) perform . During year follow-up number paracentesis patient require , incidence renal failure EH relationship hormonal activity cytokine level , free transplant survival quality life record .</brief_summary>
	<brief_title>Effect Midodrine Albumine Prevention Complications Cirrhotic Patients Awaiting Liver Transplantation</brief_title>
	<detailed_description>End point : To evaluate effect long term administration albumin midodrine prevention complication associate cirrhosis patient cirrhosis await liver transplantation . Secondary end point : - To evaluate improvement ascites control - To evaluate survival 6 12 month . - To evaluate relationship development complication activity vasoconstrictor system ( renin , aldosterone norepinephrine ) well level cytokine ( TNF , IL6 IL10 ) - To evaluate quality life - To evaluate presence outcome MHE</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>Patients cirrhosis wait list liver transplant Patients ascites diuretic treatment To write inform consent Systolic blood pressure ≥150 mmHg diastolic blood pressure≥90 mmHg To treat transjugular intrahepatic portosystemic shunt ( TIPS ) surgical shunt Antibiotic treatment previous week inclusion study Respiratory cardiac failure HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>renal failure</keyword>
	<keyword>midodrine</keyword>
	<keyword>albumine</keyword>
</DOC>